Lv3
240 积分 2023-04-21 加入
Varnimcabtagene autoleucel for adults with relapsed or refractory B-cell precursor acute lymphoblastic leukaemia in Spain (CART19-BE-02): a multicentre, single-arm, phase 2 trial
8天前
已完结
Infections Post-CAR-T Therapy: A Real-World Pharmacovigilance Analysis of the FDA Adverse Event Reporting System (FAERS) Database
8天前
已完结
Blinatumomab Nonresponse Correlates with Poor Survival After Brexucabtagene
11天前
已关闭
Nanomaterial-Based Immunotherapy of Acute Myeloid Leukemia via Tumor Microenvironment Reshaping
26天前
已完结
Predictive value of next-generation sequencing-based minimal residual disease after CAR-T cell therapy
2个月前
已完结
Safety Assessment of Budesonide/Formoterol: Real-World Pharmacovigilance Analysis Using the FAERS, JADER, and CVAR Databases
2个月前
已完结
A Multifunctional Prodrug with the DNA Damage Amplification Effect for Inducing Immunogenic Cell Death
3个月前
已完结
CD371-Targeted CAR T cells Secreting Interleukin-18 Exhibit Robust Expansion and Clear Refractory Acute Myeloid Leukemia
3个月前
已完结
Epigenetic landscapes drive CAR-T cell kinetics and fate decisions: Bridging persistence and resistance
3个月前
已完结
Emerging role of immunogenic cell death in cancer immunotherapy: Advancing next-generation CAR-T cell immunotherapy by combination
3个月前
已完结
皖公网安备34019202002308
